{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T06:03:17Z","timestamp":1794895397906,"version":"4.9.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82200081"],"award-info":[{"award-number":["82200081"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-025-03273-y","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T10:28:19Z","timestamp":1748082499000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["First nomogram for predicting interstitial lung disease and pulmonary arterial hypertension in SLE: a machine learning approach"],"prefix":"10.1186","volume":"26","author":[{"given":"Qian","family":"Niu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaijun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linjie","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,24]]},"reference":[{"key":"3273_CR1","doi-asserted-by":"crossref","unstructured":"Cho SK, Jeon Y, Kim JH, Jang EJ, Jung SY, Sung YK. Mortality patterns of SLE and the associated risk factors in Korean patients: a nationwide cohort study. Lupus Sci Med. 2025;12(1).","DOI":"10.1136\/lupus-2024-001361"},{"issue":"3","key":"3273_CR2","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1007\/s12016-022-08926-0","volume":"63","author":"E De Zorzi","year":"2022","unstructured":"De Zorzi E, Spagnolo P, Cocconcelli E, et al. Thoracic involvement in systemic autoimmune rheumatic diseases: pathogenesis and management. Clin Rev Allergy Immunol. 2022;63(3):472\u201389.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"8","key":"3273_CR3","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/resp.14703","volume":"29","author":"L Deneuville","year":"2024","unstructured":"Deneuville L, Mageau A, Debray MP, et al. Chronic interstitial lung disease associated with systemic lupus erythematosus: a multicentric study of 89 cases. Respirol (Carlton Vic). 2024;29(8):713\u201321.","journal-title":"Respirol (Carlton Vic)"},{"issue":"1","key":"3273_CR4","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12931-023-02522-2","volume":"24","author":"J Qu","year":"2023","unstructured":"Qu J, Li M, Zhang X, et al. A prognostic model for systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study. Respir Res. 2023;24(1):220.","journal-title":"Respir Res"},{"issue":"4","key":"3273_CR5","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1378\/chest.15-0300","volume":"148","author":"HW Farber","year":"2015","unstructured":"Farber HW, Miller DP, Poms AD, et al. Five-year outcomes of patients enrolled in the REVEAL registry. Chest. 2015;148(4):1043\u201354.","journal-title":"Chest"},{"issue":"4","key":"3273_CR6","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1183\/09031936.00182813","volume":"44","author":"YJ Hao","year":"2014","unstructured":"Hao YJ, Jiang X, Zhou W, et al. Connective tissue disease-associated pulmonary arterial hypertension in Chinese patients. Eur Respir J. 2014;44(4):963\u201372.","journal-title":"Eur Respir J"},{"issue":"5","key":"3273_CR7","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.semarthrit.2020.06.005","volume":"50","author":"CY Lin","year":"2020","unstructured":"Lin CY, Ko CH, Hsu CY, Chen HA. Epidemiology and mortality of connective tissue disease-associated pulmonary arterial hypertension: a national cohort study in Taiwan. Semin Arthritis Rheum. 2020;50(5):957\u201362.","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"3273_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10067-013-2383-3","volume":"33","author":"Y Fei","year":"2014","unstructured":"Fei Y, Shi X, Gan F, et al. Death causes and pathogens analysis of systemic lupus erythematosus during the past 26 years. Clin Rheumatol. 2014;33(1):57\u201363.","journal-title":"Clin Rheumatol"},{"issue":"2","key":"3273_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1164\/rccm.200806-953OC","volume":"179","author":"R Condliffe","year":"2009","unstructured":"Condliffe R, Kiely DG, Peacock AJ, et al. Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med. 2009;179(2):151\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"3273_CR10","doi-asserted-by":"crossref","unstructured":"Qian J, Li M, Zhang X et al. Long-term prognosis of patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study. Eur Respir J. 2019;53(2).","DOI":"10.1183\/13993003.00081-2018"},{"issue":"1","key":"3273_CR11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.chest.2017.08.014","volume":"153","author":"E Hachulla","year":"2018","unstructured":"Hachulla E, Jais X, Cinquetti G, et al. Pulmonary arterial hypertension associated with systemic lupus erythematosus: results from the French pulmonary hypertension registry. Chest. 2018;153(1):143\u201351.","journal-title":"Chest"},{"issue":"10","key":"3273_CR12","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1002\/art.41740","volume":"73","author":"J Qu","year":"2021","unstructured":"Qu J, Li M, Wang Y, et al. Predicting the risk of pulmonary arterial hypertension in systemic lupus erythematosus: a Chinese systemic lupus erythematosus treatment and research group cohort study. Arthritis Rheumatol (Hoboken N J). 2021;73(10):1847\u201355.","journal-title":"Arthritis Rheumatol (Hoboken N J)"},{"issue":"51","key":"3273_CR13","doi-asserted-by":"publisher","first-page":"e36654","DOI":"10.1097\/MD.0000000000036654","volume":"102","author":"X Lun","year":"2023","unstructured":"Lun X, Yang J, Liu Y, et al. Risk factors of systemic lupus erythematosus patients with pulmonary arterial hypertension: a systematic review and meta-analysis. Medicine. 2023;102(51):e36654.","journal-title":"Medicine"},{"issue":"11","key":"3273_CR14","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1177\/09612033231202398","volume":"32","author":"Y Liu","year":"2023","unstructured":"Liu Y, Cheng Z, Zha B, et al. Risk factors of pulmonary arterial hypertension in patients with systemic lupus erythematosus: a meta-analysis. Lupus. 2023;32(11):1310\u20139.","journal-title":"Lupus"},{"issue":"11","key":"3273_CR15","doi-asserted-by":"publisher","first-page":"5351","DOI":"10.1093\/rheumatology\/keab118","volume":"60","author":"HH Chen","year":"2021","unstructured":"Chen HH, Lin CH, Hsieh TY, Chen DY, Ying JC, Chao WC. Factors associated with incident severe pulmonary arterial hypertension in systemic autoimmune rheumatic diseases: a nationwide study. Rheumatology (Oxford). 2021;60(11):5351\u201361.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"3273_CR16","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/art.1780350606","volume":"35","author":"C Bombardier","year":"1992","unstructured":"Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum. 1992;35(6):630\u201340.","journal-title":"Arthritis Rheum"},{"issue":"12","key":"3273_CR17","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/eurheartj\/ehv512","volume":"37","author":"S Rosenkranz","year":"2016","unstructured":"Rosenkranz S, Gibbs JS, Wachter R, De Marco T, Vonk-Noordegraaf A, Vachi\u00e9ry JL. Left ventricular heart failure and pulmonary hypertension. Eur Heart J. 2016;37(12):942\u201354.","journal-title":"Eur Heart J"},{"issue":"25 Suppl","key":"3273_CR18","doi-asserted-by":"publisher","first-page":"D42","DOI":"10.1016\/j.jacc.2013.10.032","volume":"62","author":"MM Hoeper","year":"2013","unstructured":"Hoeper MM, Bogaard HJ, Condliffe R, et al. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 Suppl):D42\u201350.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"3273_CR19","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1164\/rccm.201509-1881ED","volume":"192","author":"D Khanna","year":"2015","unstructured":"Khanna D, McLaughlin V. Screening and early detection of pulmonary arterial hypertension in connective tissue diseases. It is time to Institute it! Am J Respir Crit Care Med. 2015;192(9):1032\u20133.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"3273_CR20","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1164\/rccm.200811-1691OC","volume":"179","author":"MR Fisher","year":"2009","unstructured":"Fisher MR, Forfia PR, Chamera E, et al. Accuracy of doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med. 2009;179(7):615\u201321.","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"3273_CR21","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/acr2.11611","volume":"5","author":"T Atsumi","year":"2023","unstructured":"Atsumi T, Bae SC, Gu H, et al. Risk factors for pulmonary arterial hypertension in patients with systemic lupus erythematosus: a systematic review and expert consensus. ACR Open Rheumatol. 2023;5(12):663\u201376.","journal-title":"ACR Open Rheumatol"},{"key":"3273_CR22","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.2147\/IJGM.S449068","volume":"17","author":"NA Alhammadi","year":"2024","unstructured":"Alhammadi NA, Alqahtani HS, Mahmood SE, et al. Pulmonary manifestations of systemic lupus erythematosus among adults in Aseer region, Saudi Arabia. Int J Gen Med. 2024;17:1007\u201315.","journal-title":"Int J Gen Med"},{"issue":"1","key":"3273_CR23","doi-asserted-by":"publisher","first-page":"10101","DOI":"10.1038\/s41598-023-37100-5","volume":"13","author":"M Gong","year":"2023","unstructured":"Gong M, Dai L, Xie Z, et al. Serological and clinical associations of autoantibodies in Chinese patients with new-onset systemic lupus erythematosus. Sci Rep. 2023;13(1):10101.","journal-title":"Sci Rep"},{"key":"3273_CR24","doi-asserted-by":"publisher","first-page":"102900","DOI":"10.1016\/j.jaut.2022.102900","volume":"132","author":"M Bruschi","year":"2022","unstructured":"Bruschi M, Angeletti A, Kajana X, et al. Evidence for charge-based mimicry in anti DsDNA antibody generation. J Autoimmun. 2022;132:102900.","journal-title":"J Autoimmun"},{"issue":"2","key":"3273_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S1568-9972(03)00082-X","volume":"3","author":"C Putterman","year":"2004","unstructured":"Putterman C. New approaches to the renal pathogenicity of anti-DNA antibodies in systemic lupus erythematosus. Autoimmun Rev. 2004;3(2):7\u201311.","journal-title":"Autoimmun Rev"},{"key":"3273_CR26","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.3389\/fimmu.2019.01667","volume":"10","author":"X Wang","year":"2019","unstructured":"Wang X, Xia Y, Anti-double Stranded DNA. Antibodies: origin, pathogenicity, and targeted therapies. Front Immunol. 2019;10:1667.","journal-title":"Front Immunol"},{"issue":"1","key":"3273_CR27","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s13075-018-1776-8","volume":"20","author":"J Narv\u00e1ez","year":"2018","unstructured":"Narv\u00e1ez J, Borrell H, S\u00e1nchez-Alonso F, et al. Primary respiratory disease in patients with systemic lupus erythematosus: data from the Spanish rheumatology society lupus registry (RELESSER) cohort. Arthritis Res Therapy. 2018;20(1):280.","journal-title":"Arthritis Res Therapy"},{"issue":"1","key":"3273_CR28","first-page":"76","volume":"52","author":"N \u015eenkal","year":"2022","unstructured":"\u015eenkal N, K\u0131yan E, Demir AA, et al. Interstitial lung disease in patients with systemic lupus erythematosus: a cohort study. Turk J Med Sci. 2022;52(1):76\u201382.","journal-title":"Turk J Med Sci"},{"issue":"4","key":"3273_CR29","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1152\/physrev.00038.2015","volume":"96","author":"EA Middleton","year":"2016","unstructured":"Middleton EA, Weyrich AS, Zimmerman GA. Platelets in pulmonary immune responses and inflammatory lung diseases. Physiol Rev. 2016;96(4):1211\u201359.","journal-title":"Physiol Rev"},{"issue":"5","key":"3273_CR30","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/1756-185X.13478","volume":"22","author":"N Zhang","year":"2019","unstructured":"Zhang N, Li M, Qian J, et al. Pulmonary arterial hypertension in systemic lupus erythematosus based on a CSTAR-PAH study: baseline characteristics and risk factors. Int J Rheum Dis. 2019;22(5):921\u20138.","journal-title":"Int J Rheum Dis"},{"issue":"10","key":"3273_CR31","doi-asserted-by":"publisher","first-page":"e2761","DOI":"10.1097\/MD.0000000000002761","volume":"95","author":"C Huang","year":"2016","unstructured":"Huang C, Li M, Liu Y, et al. Baseline characteristics and risk factors of pulmonary arterial hypertension in systemic lupus erythematosus patients. Medicine. 2016;95(10):e2761.","journal-title":"Medicine"},{"issue":"6","key":"3273_CR32","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1177\/0961203315625460","volume":"25","author":"J Zhao","year":"2016","unstructured":"Zhao J, Bai W, Zhu P, et al. Chinese SLE treatment and research group (CSTAR) registry VII: prevalence and clinical significance of serositis in Chinese patients with systemic lupus erythematosus. Lupus. 2016;25(6):652\u20137.","journal-title":"Lupus"},{"issue":"1","key":"3273_CR33","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13075-019-1868-0","volume":"21","author":"HA Chen","year":"2019","unstructured":"Chen HA, Hsu TC, Yang SC, et al. Incidence and survival impact of pulmonary arterial hypertension among patients with systemic lupus erythematosus: a nationwide cohort study. Arthritis Res Therapy. 2019;21(1):82.","journal-title":"Arthritis Res Therapy"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03273-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-025-03273-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03273-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T10:28:21Z","timestamp":1748082501000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-025-03273-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,24]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3273"],"URL":"https:\/\/doi.org\/10.1186\/s12931-025-03273-y","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,24]]},"assertion":[{"value":"1 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"197"}}